Cannabis

Glaucoma And Medical Marijuana: 5 Informative Facts

Published

2 years ago

April 17, 2023

admin

Glaucoma is the second leading cause of blindness (cataracts are number 1) with about 3.5 million Americana and Canadian’s suffering through this disease. It is a gradual loss of vision caused by damage to the optic nerve making it tough for improvement. It comes in several varieties, but essentially the culprit is increased interocular pressure (IOP) caused by a build up of fluid in the eye.

What Is Medical Marijuana Glaucoma Treatment? The discovery of cannabis’s glaucoma-fighting power was happy accident in the War on Drugs. In the early 1970s, a group of UCLA researchers, led by Drs. Robert Hepler and Thomas Ungerleider, began studying the telltale marijuana “red eye” and pupil dilation in hopes of somehow using the phenomena to help the DEA to narc out stoners. The real takeaway, however, was something not at all expected: Cannabis—particularly the THC in cannabis—reduced eye pressure by 25 to 30 percent. That result is currently as good as any produced by an FDA-approved glaucoma medication.

What’s the Catch? Unfortunately, the effect cannabis has on IOP lasts only about three hours, and THC, the element most responsible for pressure relief, is also the most psychoactively potent. To be completely treated, you’d need to smoke around six or seven joints a day. The potency can vary so you could vape or have low dosage preroll – but you would still be dependent on THC hitting your system often.

What Do the Pros Say? Neither the American Association of Ophthalmology, American Glaucoma Society, nor the Glaucoma Research Foundation endorses medical marijuana glaucoma treatment. This is partially because they view having a perpetual pot high as a less-than-optimal way of being in the world, but they also have a medical reason: Lowered blood flow can damage the optic nerve, and one of the side effects of cannabis is to lower blood pressure. Ironically, then, pot can both ease glaucoma and make it worse.

What’s Next? A topical treatment could be a way of sidestepping the intoxicating side effects of smoked or ingested cannabis. THC eyedrops have been tested, but there are practical hurdles to clear: THC dissolves best in alcohol or oil—neither of which is something you want to put in your eye. Saline-based THC eye drops, at least at the moment, can’t deliver a powerful enough does. More troubling, topical THC can damage the surface of the eye. But this doesn’t mean that THC therapy is at an impasse, just that more research and testing is needed.

Bonus, Non-Glaucoma Factoid: Dr. Hepler’s team also found that cannabis suppresses tear production. While that’s bad news for wearers of contact lenses, one canny housewife reported that toking up was a prophylactic against that well known culinary malady: chopped-onion induced lachrymosity.

Source link

Cannabis

White House Finally Comments On Marijuana Industry

Published

8 hours ago

April 1, 2025

admin

Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.

The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.

The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.

During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.

The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.

The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.

While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.

Source link

Cannabis

This State’s Cannabis Revenue Keeps Pouring In

Published

1 day ago

March 31, 2025

admin

States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.

The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.

RELATED: Mike Johnson And Marijuana

“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”

Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.

States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.

In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.

Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.

The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.

This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.

Source link

Cannabis

Mixed Messages From The Feds About Cannabis

Published

4 days ago

March 28, 2025

admin

The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.

The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.

The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.

The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.

Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.

In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.

This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.

Source link